Barclays
NSPR icon

Barclays’s InspireMD NSPR Stock Holding History

Barclays’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,929
Closed -$18K – 6043
2020
Q1 		$18K Buy
1,929
+31
+2% +$448 ﹤0.01% 5674
2019
Q4 		$31K Buy
1,898
+646
+52% +$10.2K ﹤0.01% 5882
2019
Q3 		$24K Buy
+1,252
New +$50.6K ﹤0.01% 6169
2019
Q1 		– Sell
-217
Closed -$26K – 7228
2018
Q4 		$26K Buy
+217
New +$34.5K ﹤0.01% 5781
2018
Q3 		– Sell
-23
Closed -$4K – 7303
2018
Q2 		$4K Buy
23
+7
+44% +$5.94K ﹤0.01% 6745
2018
Q1 		$12K Buy
+16
New +$55.1K ﹤0.01% 6606

Other funds holding NSPR

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays's NSPR Position: Q2 2020 in Review

Barclays sold out of InspireMD (NSPR) in Q2 2020, closing a stake of 1,929 shares — an estimated $18K sold.

Barclays first reported a position in NSPR in Q1 2018 and held it in 6 quarters. The position peaked at $31K in Q4 2019. 15 funds tracked by Wall St. Rank hold NSPR as of Q2 2020.

  • Barclays reported no remaining InspireMD position as of Q2 2020 after selling out during the quarter.
  • Barclays sold 1,929 InspireMD shares in Q2 2020, an estimated $18K.
  • Barclays first reported a position in InspireMD in Q1 2018 and held it in 6 quarters.
  • Barclays's InspireMD position peaked at $31K in Q4 2019.
  • 15 funds tracked by Wall St. Rank held InspireMD as of Q2 2020.

Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.